Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups: Complete Statistical AnalysisIndependent statistical analysis of SmokefreeSGM, A Text-based Smoking Cessation Intervention for Sexual and Gender Minority Groups: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Smoking Cessation E-Visit: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation E-Visit: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04316260).
- Smoking Cessation for Smokers With Sleep Problems: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation for Smokers With Sleep Problems: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01277887).
- Smoking Cessation in Alcoholics: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation in Alcoholics: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00963482).
- Smoking Cessation in Hispanic Construction Workers: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation in Hispanic Construction Workers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02873377).
- Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation in Subjects With Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD).: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Smoking Cessation Intervention for Thoracic Patients: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation Intervention for Thoracic Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00580398).
- Smoking Cessation Intervention in Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation Intervention in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03024606).
- Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation Interventions for People Living With HIV in Nairobi, Kenya: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms: Complete Statistical AnalysisIndependent statistical analysis of Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00332644).
- Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation: Complete Statistical AnalysisIndependent statistical analysis of Smoking While on Transdermal Nicotine Replacement Therapy: Effects on Craving and Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Smoking, Stress, HIV and Mobile Technology: Complete Statistical AnalysisIndependent statistical analysis of Smoking, Stress, HIV and Mobile Technology: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05709002).
- SMS TurkeyIndependent statistical analysis of SMS Turkey: Harnessing the Power of Text Messaging to Promote Smoking Cessation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SMV + SOF With/Without RBV for IFN-II Patients With CHC: Complete Statistical AnalysisIndependent statistical analysis of SMV + SOF With/Without RBV for IFN-II Patients With CHC: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02214420).
- SNIFFLE-3Independent statistical analysis of Efficacy & Safety of Nasal Influenza Immunisation in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02549365).
- SNO-1Independent statistical analysis of Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SNO2Independent statistical analysis of MAD Study Evaluating the Safety, Tolerability, and Pharmacokinetic Effects of N91115 in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- SNP Study of DPP-4 and GLP-1R in Chinese People (Including Diabetes Patients): Complete Statistical AnalysisIndependent statistical analysis of SNP Study of DPP-4 and GLP-1R in Chinese People (Including Diabetes Patients): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- SOCIALIndependent statistical analysis of Supporting Our Caregivers In ADRD Learning (SOCIAL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT06276023).
- Social Media HIV Prevention Intervention for High Risk Rural Women: Complete Statistical AnalysisIndependent statistical analysis of Social Media HIV Prevention Intervention for High Risk Rural Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03456453).
- Social Media Intervention for Cannabis Use in Emerging Adults: Complete Statistical AnalysisIndependent statistical analysis of Social Media Intervention for Cannabis Use in Emerging Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04187989).
- Social Network Diffusion of COVID-19 Prevention for Diverse Criminal Legal Involved Communities: Complete Statistical AnalysisIndependent statistical analysis of Social Network Diffusion of COVID-19 Prevention for Diverse Criminal Legal Involved Communities: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Social Virtual-reality on Enhancing Social Interaction Skills in Children With Attention-deficit/Hyperactivity Disorder: Complete Statistical AnalysisIndependent statistical analysis of Social Virtual-reality on Enhancing Social Interaction Skills in Children With Attention-deficit/Hyperactivity Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Social-LEAF Life Enhancing Activities for Caregivers: Complete Statistical AnalysisIndependent statistical analysis of Social-LEAF Life Enhancing Activities for Caregivers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05274074).
- Socially Assistive Robots for Interaction With Older Adults With Dementia: Complete Statistical AnalysisIndependent statistical analysis of Socially Assistive Robots for Interaction With Older Adults With Dementia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04384978).
- SoCIWHIVIndependent statistical analysis of Smoking Cessation Intervention for Women Living With HIV: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02898597).
- SOCRIndependent statistical analysis of Sensor Optimization of Cardiac Resynchronization Therapy Response: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01832493).
- SOCRATESIndependent statistical analysis of [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration: Complete Statistical AnalysisIndependent statistical analysis of Sodium Chloride and Protein-Bound Toxin Removal in Hemodiafiltration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01923961).
- Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors: Complete Statistical AnalysisIndependent statistical analysis of Sodium Fluorescein-Guided Resection of Pediatric Neurosurgical Tumors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03752203).
- Sodium Nitroprusside in Early Course Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Sodium Nitroprusside in Early Course Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04986072).
- Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection: Complete Statistical AnalysisIndependent statistical analysis of Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04824365).
- Sodium Risedronate Tablets – Special Drug Use Surveillance in Patients With Osseous Paget’s Disease (All-case Surveillance) -48-week Surveillance -: Complete Statistical AnalysisIndependent statistical analysis of Sodium Risedronate Tablets - Special Drug Use Surveillance in Patients With Osseous Paget's Disease (All-case Surveillance) -48-week Surveillance -: primary endpoint results, effect estimate with confidence interval, sample-size…
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy: Complete Statistical AnalysisIndependent statistical analysis of Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy: primary endpoint results, effect…
- SOF/VEL ESRDIndependent statistical analysis of Sofosbuvir/Velpatasvir in Adults With Chronic Hepatitis C Virus Infection Who Are on Dialysis for End Stage Renal Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation: Complete Statistical AnalysisIndependent statistical analysis of Sofosbuvir and Ribavirin in Patients With Chronic HCV With Cirrhosis and Portal Hypertension With or Without Liver Decompensation: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection: Complete Statistical AnalysisIndependent statistical analysis of Sofosbuvir and Ribavirin in Treatment-Naive and Treatment-Experienced Subjects With Chronic Genotype 2 or 3 HCV Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection: Complete Statistical AnalysisIndependent statistical analysis of Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection: primary endpoint results,…
- SOFTIndependent statistical analysis of Bladder Drainage During Labor: A Randomized Controlled Study of Obstetric Foley Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere: Complete Statistical AnalysisIndependent statistical analysis of Soft Lens Study: Biomedics 1 Day Extra Sphere and Clariti 1 Day Sphere: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Soft Tissue Mobilization Versus Therapeutic Ultrasound for Subjects With Neck and Arm Pain: Complete Statistical AnalysisIndependent statistical analysis of Soft Tissue Mobilization Versus Therapeutic Ultrasound for Subjects With Neck and Arm Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SOFT-ESTIndependent statistical analysis of Study of Estrogen Levels in Premenopausal Women Who Have Undergone Surgery for Breast Cancer and Are Receiving Triptorelin and Tamoxifen Citrate or Exemestane on Clinical Trial IBCSG 24-02:…
- Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant: Complete Statistical AnalysisIndependent statistical analysis of Software Treatment for Actively Reducing Severity of ADHD as Adjunctive Treatment to Stimulant: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- SOLANAIndependent statistical analysis of A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation: primary endpoint…
- SOLARIndependent statistical analysis of Supplementation of VigantOL® Oil Versus Placebo as Add-on in Patients With Relapsing Remitting Multiple Sclerosis Receiving Rebif® Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- SOLAR-1Independent statistical analysis of Study Assessing the Efficacy and Safety of Alpelisib Plus Fulvestrant in Men and Postmenopausal Women With Advanced Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment.: primary…
- SOLEOIndependent statistical analysis of A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- SOLMYD-PDIndependent statistical analysis of Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- SOLO3Independent statistical analysis of Olaparib Treatment in Relapsed Germline Breast Cancer Susceptibility Gene (BRCA) Mutated Ovarian Cancer Patients Who Have Progressed at Least 6 Months After Last Platinum Treatment and Have Received…
- SolsticeIndependent statistical analysis of A Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial…